SNDX · Company research
Syndax Pharmaceuticals, Inc. (SNDX): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 17.37 | $1,505,747,380.92 | 1169270380.92 | — | — | — | 10.8808523319675704 | — | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.